In accordance, glioma cell lines expressing HLA-G are resistant to allo-reactive lysis (Wiendl et al., 2002), and HLA-G-positive melanoma cell lines are protected from NK cell cytolysis (Cabestre et al., 1999). The gene discussed is HLA-G; the disease is glioma.